Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?

Source:http://linkedlifedata.com/resource/pubmed/id/16792781

Download in:

View as

General Info

PMID
16792781